PDCD1 and neoplasm: PD-1 expression was also higher for the CAR-T–treated group in tumor-bearing tibia versus spleen (P < 0.0006) and versus blood (P < 0.0001), but no statistically significant differences were observed among the T cells that infiltrate the bone.